|
|
Other links at Articles > Pharmacists |
| 1. |
Nimotuzumab Boosts Effect of Ionizing Radiation Against Some NSCLCs
|
|
|
Nimotuzumab enhances the antitumor activity of ionizing radiation in non-small-cell lung cancer (NSCLC) cell lines showing high or moderate expression of epidermal growth factor receptor (EGFR), according to a report in the February 26th issue of the British Journal of Cancer. Reuters Health Information
|
|
|